About HLS Therapeutics Inc.
The Heritage of Life Sciences
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Etobicoke, ON
- Founded
- 2015
- Company type
- Public Company
Stewards of Trusted Brands
HLS Therapeutics Inc. (TSX:HLS) specializes in the acquisition and commercialization of pharmaceuticals focused on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. We are dedicated to introducing novel therapies in Canada and the United States and ensuring that trusted branded medicines are readily accessible to healthcare providers & patients. Led by a team of executives with deep expertise in product development and commercialization, HLS Therapeutics Inc. maintains operational locations in the Toronto, Montreal, and Philadelphia metropolitan areas.
Experienced across all stages of the product lifecycle
Our team has a wealth of experience with each stage of the pharmaceutical lifecycle, from late-stage development to new product launch and commercial-stage promotion. Our team is committed to expanding access to quality treatments critical to healthcare providers, patients, and their caregivers.
Specialties
- Life Sciences
- Cardiovascular
- Neuroscience
- Psychiatric Disorders
- and Cardiovascular Disease
Company locations
10 Carlson Court, Suite 410, Etobicoke, ON M9W 6L2, CA
1375 Trans Canada Highway, Suite 610, Dorval, QC H9P 2W8, CA
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
On LinkedIn
- Followers
- 11,280
- People linked to this company
- 95
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.